Clinical and treatment profiles of arterial hypertension in Mexico during the COVID-19 pandemic: a cross-sectional survey endorsed by the 'Collaborative Group on Arterial Hypertension'

Autor: Silvia Palomo-Piñón, Neftali Eduardo Antonio-Villa, Ricardo Alfonso Rangel-Zertuche, María Guadalupe Berumen-Lechuga, Julio Manuel Medina-Serrano, Luis Rey García-Cortés, Oliva Mejia-Rodríguez, María de la Luz León-Vázquez, Roxana del Socorro González-Dzib, Vidal José González-Coronado, Cleto Álvarez-Aguilar, José Ramón Paniagua-Sierra, Luis Alcocer, the Collaborative Group on Arterial Hypertension from the Mexican Institute of Social Security
Jazyk: angličtina
Rok vydání: 2024
Předmět:
Zdroj: Frontiers in Public Health, Vol 12 (2024)
Druh dokumentu: article
ISSN: 2296-2565
90892704
DOI: 10.3389/fpubh.2024.1385349
Popis: BackgroundArterial hypertension is highly prevalent in Mexico; nevertheless, there are limited insights regarding its management during the COVID-19 pandemic. Here, we estimate the prevalence of clinical and treatment profiles of arterial hypertension and explore associated factors for undiagnosed and uncontrolled hypertension using a cross-sectional survey endorsed by the Collaborative Group on Arterial Hypertension from the Mexican Institute of Social Security.MethodsOur survey was conducted from May to November 2021 using the May-Measurement Month 2021 protocols of the International Society of Hypertension. Arterial hypertension (defined as: blood pressure [BP] ≥140/90 mmHg, previous diagnosis, or taking antihypertensives) and its clinical and treatment profiles were classified according to the World Hypertension League Expert Committee. Mixed-effects logistic regression models were used to explore associated factors for undiagnosed and uncontrolled hypertension.ResultsAmong 77,145 screened participants (women: 62.4%; median age: 46 [IQR: 32–59] years), the prevalence of arterial hypertension was 35.7% (95% CI: 35.3–36.0, n = 27,540). Among participants with arterial hypertension, 30.9% (95% CI: 30.4–31.5, n = 8,533) were undiagnosed, 6.6% (95% CI: 6.3%−6.9%, n = 1,806) were diagnosed but untreated, 43.4% (95% CI: 42.9–44.0, n = 11,965) had uncontrolled hypertension, and only 19% (95% CI: 18.6%−19.5%, n = 5,236) achieved hypertension control (BP < 130/80 mmHg). Explored associated factors for undiagnosed and uncontrolled hypertension include being men, living in the central and southern regions, lower educational attainments, higher use of pharmacological agents, and previous COVID-19 infection.ConclusionOur findings suggest that adverse arterial hypertension profiles, mainly undiagnosed and uncontrolled hypertension, were highly prevalent during the context of the COVID-19 pandemic in Mexico.
Databáze: Directory of Open Access Journals
Externí odkaz: